Search results
By Masahiko Shibuya, MD, PhD, and Yuji Okuno, MD, PhD. View PDF Reprints. Osteoarthritis (OA) is a leading cause of disability and chronic pain that reduces physical activity and quality of life. The prevalence of knee OA has been rising because of the increasing aging population and the obesity epidemic.
Purpose: To evaluate the safety and 2-year follow-up clinical outcomes of transcatheter arterial embolization (TAE) using imipenem/cilastatin sodium for chronic low back pain resistant to conservative treatment.
経歴. 2004年 兵庫医科大学卒業後循環器内科医として心臓血管カテーテル治療に従事。. 2012年11月〜2014年10月 アメリカSkirball Center for Innovation (ニューヨーク州、血管内治療デバイス研究施設)に研究留学。. 2016年3月 大学院博士課程修了 研究テーマ「冠動脈 ...
This case report concerns a 51-year-old woman with a 6-month history of severe right heel pain diagnosed as plantar fasciitis (PF) treated with intra-arterial infusion of imipenem/cilastatin (IPM/CS) through a 24G indwelling needle directly inserted into the posterior tibial artery (PTA).
- Masahiko Shibuya, Eiji Sugihara, Koichi Miyazaki, Keishi Fujiwara, Takayuki Sakugawa, Yuji Okuno
- 2021
Yuji Okuno 1 , Masahiko Shibuya 2 Affiliations 1 Musculoskeletal Intervention Center, Okuno Clinic, 4th Fl Ginrei Bldg, 7-8-4 Minato-ku, Roppongi, Tokyo, 106-0032, Japan. okuno@okuno-y-clinic.com.
View the profiles of people named Masahiko Shibuya. Join Facebook to connect with Masahiko Shibuya and others you may know. Facebook gives people the...
Masahiko Shibuya's 7 research works with 13 citations and 220 reads, including: Two-year outcomes comparing Embosphere® microspheres versus Imipenem Cilastatin for genicular artery...
